Archive · 15 Jan 2026
Biocon raises ₹4,150 crore via QIP
Biocon, a big Indian company, raised a lot of money (₹4,150 crore) by selling new shares to big investors like SBI and ICICI.
They sold these shares at a small discount.
The money will be used to buy more shares in another company called Biocon Biologics and to pay back some loans.
After this, Biocon will own all of Biocon Biologics.
The company's shares went up a little bit after this news.
Biocon raised ₹4,150 crore through a Qualified Institutional Placement (QIP).
The QIP issued 11.26 crore shares at ₹368.35 per share, a 2.8% discount to the previous closing price.
Major investors include SBI, ICICI, and Mirae Mutual Funds, who received nearly two-thirds of the shares.
Proceeds will be used to pay Mylan Inc. for Biocon Biologics shares and to repay debt.
Biocon aims to make Biocon Biologics a 100% subsidiary by issuing shares to existing shareholders.
- Who
- Biocon Ltd.
- What
- Raised ₹4,150 crore through QIP
- When
- January 15
- Where
- India
- Why
- To pay Mylan for Biocon Biologics shares and repay debt
- Amount Raised
- ₹4,150 crore
- Shares Issued
- 11.26 crore
- Price per Share
- ₹368.35
- Discount to Closing Price
- 2.8%
- Major Investors
- SBI, ICICI, Mirae Mutual Funds
- Total Paid-up Equity
- ₹810.45 crore
- Total Shares
- 162.09 crore
- Payment to Mylan
- $400 million